SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001367644-20-000134
Filing Date
2020-08-12
Accepted
2020-08-12 16:52:50
Documents
1
Period of Report
2020-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159726555510283.html 4  
1 FORM 4 wf-form4_159726555510283.xml 4 3462
  Complete submission text file 0001367644-20-000134.txt   4708
Mailing Address
Business Address
JOULWAN GEORGE A (Reporting) CIK: 0001222197 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33137 | Film No.: 201096009

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations